🇺🇸 FDA
Patent

US 8945858

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

granted A61PA61P25/28A61P43/00

Quick answer

US patent 8945858 (Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory) held by The Regents of the University of California expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P25/28, A61P43/00